UK markets open in 9 minutes
NIKKEI 225
38,787.38 -132.88 (-0.34%) HANG SENG
19,526.92 +150.39 (+0.78%) CRUDE OIL
79.57 +0.34 (+0.43%) GOLD FUTURES
2,390.10 +4.60 (+0.19%) DOW
39,869.38 -38.62 (-0.10%) Bitcoin GBP
52,091.85 +0.49 (+0.00%)
Bristol-Myers Squibb Company (BRM.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
At close: 05:35PM CEST
| Previous close | 41.17 |
| Open | 41.19 |
| Bid | 40.26 x 37000 |
| Ask | 40.31 x 43000 |
| Day's range | 40.24 - 41.62 |
| 52-week range | 40.24 - 62.10 |
| Volume | |
| Avg. volume | 2,831 |
| Market cap | 82.115B |
| Beta (5Y monthly) | 0.44 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.84 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 2.25 (5.59%) |
| Ex-dividend date | 04 Apr 2024 |
| 1y target est | N/A |
ZacksWalmart Earnings & the State of the Consumer
We discuss what Walmart's blockbuster results tell us about the health of the consumer economy.
ZacksBiotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
Business WireNew Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
PRINCETON, N.J., May 16, 2024--New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
© 2024 Yahoo. All rights reserved.